140 related articles for article (PubMed ID: 24150997)
1. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
Wijemanne S; Wu LJ; Jankovic J
Mov Disord; 2014 Jan; 29(1):126-30. PubMed ID: 24150997
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment.
Singer HS; Gammon K; Quaskey S
Pediatr Neurosci; 1985-1986; 12(2):71-4. PubMed ID: 3870139
[TBL] [Abstract][Full Text] [Related]
3. [Two cases of tardive Tourette syndrome].
Yamauchi K; Ohmori T
Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
[TBL] [Abstract][Full Text] [Related]
4. Fluphenazine and multifocal tic disorders.
Goetz CG; Tanner CM; Klawans HL
Arch Neurol; 1984 Mar; 41(3):271-2. PubMed ID: 6582810
[TBL] [Abstract][Full Text] [Related]
5. Treatment approaches in Gilles de la Tourette syndrome.
Borison RL; Ang L; Hamilton WJ; Diamond BI; Davis JM
Brain Res Bull; 1983 Aug; 11(2):205-8. PubMed ID: 6578865
[TBL] [Abstract][Full Text] [Related]
6. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder.
Ho CS; Chen HJ; Chiu NC; Shen EY; Lue HC
J Formos Med Assoc; 2009 Oct; 108(10):788-93. PubMed ID: 19864199
[TBL] [Abstract][Full Text] [Related]
7. The natural history of Tourette syndrome: a follow-up study.
Erenberg G; Cruse RP; Rothner AD
Ann Neurol; 1987 Sep; 22(3):383-5. PubMed ID: 3479043
[TBL] [Abstract][Full Text] [Related]
8. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
[TBL] [Abstract][Full Text] [Related]
9. Tourette syndrome: clinical characteristics and current management strategies.
Kossoff EH; Singer HS
Paediatr Drugs; 2001; 3(5):355-63. PubMed ID: 11393328
[TBL] [Abstract][Full Text] [Related]
10. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.
Gilbert DL; Budman CL; Singer HS; Kurlan R; Chipkin RE
Clin Neuropharmacol; 2014; 37(1):26-30. PubMed ID: 24434529
[TBL] [Abstract][Full Text] [Related]
11. Tolerability profile of clonidine in the treatment of adults with Tourette syndrome.
Cavanna AE; Selvini C; Termine C; Balottin U; Eddy CM
Clin Neuropharmacol; 2012; 35(6):269-72. PubMed ID: 23123691
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia with Tourette-like syndrome.
Seeman MV; Patel J; Pyke J
J Clin Psychiatry; 1981 Sep; 42(9):357-8. PubMed ID: 6944306
[TBL] [Abstract][Full Text] [Related]
13. Tourette syndrome: a follow-up study.
Sandor P; Musisi S; Moldofsky H; Lang A
J Clin Psychopharmacol; 1990 Jun; 10(3):197-9. PubMed ID: 2115892
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological management of tics in patients with TS.
Sandor P
J Psychosom Res; 2003 Jul; 55(1):41-8. PubMed ID: 12842230
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs in Tourette syndrome.
Silay YS; Jankovic J
Expert Opin Emerg Drugs; 2005 May; 10(2):365-80. PubMed ID: 15934872
[TBL] [Abstract][Full Text] [Related]
16. Tolerability profile of aripiprazole in patients with Tourette syndrome.
Cavanna AE; Selvini C; Termine C; Luoni C; Eddy CM; Rickards H
J Psychopharmacol; 2012 Jun; 26(6):891-5. PubMed ID: 21824981
[TBL] [Abstract][Full Text] [Related]
17. Effects of medications on regulation of body temperature of patients with Tourette syndrome.
Kessler AR
J Child Neurol; 2004 Mar; 19(3):220-4. PubMed ID: 15119484
[TBL] [Abstract][Full Text] [Related]
18. New pharmacological approaches in the treatment of Tourette syndrome.
Borison RL; Ang L; Chang S; Dysken M; Comaty JE; Davis JM
Adv Neurol; 1982; 35():377-82. PubMed ID: 6756088
[No Abstract] [Full Text] [Related]
19. Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
Oulis P; Karapoulios E; Masdrakis VG; Kouzoupis AV; Karakatsanis NA; Papageorgiou C; Papadimitriou GN; Soldatos CR
World J Biol Psychiatry; 2008; 9(1):76-7. PubMed ID: 17853302
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of tardive dyskinesia in fluphenazine-treated patients.
Yassa R; Iskandar H; Ally J
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):17S-20S. PubMed ID: 3220966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
